Cited in:


This article has been cited by:

  1. You have free access to this content1
    Frederik Banch Clausen, Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care, Prenatal Diagnosis, 2014, 34, 5
  2. 2
    Ji He, Yanling Ying, Xiaozhen Hong, Xianguo Xu, Faming Zhu, Hangjun Lv, Molecular basis and zygosity determination of D variants including identification of four novel alleles in Chinese individuals, Transfusion, 2014, 54, 7
  3. 3
    Maryse St-Louis, Molecular blood grouping of donors, Transfusion and Apheresis Science, 2014, 50, 2, 175


  4. 4
    Frederik Banch Clausen, Merete Berthu Damkjær, Morten Hanefeld Dziegiel, Noninvasive fetal RhD genotyping, Transfusion and Apheresis Science, 2014, 50, 2, 154


  5. 5
    Stacy A. Scott, Lisa Nagl, Louise Tilley, Yew-Wah Liew, Jenny Condon, Robert Flower, Catherine A. Hyland, The RHD(1227G>A) DEL-associated allele is the most prevalent DEL allele in Australian D– blood donors with C+ and/or E+ phenotypes, Transfusion, 2014, 54, 7
  6. 6
    Lonneke Haer-Wigman, Yanli Ji, Martin Lodén, Masja Haas, C. Ellen Schoot, Barbera Veldhuisen, Comprehensive genotyping for 18 blood group systems using a multiplex ligation-dependent probe amplification assay shows a high degree of accuracy, Transfusion, 2013, 53, 11pt2
  7. 7
    Sofia Lejon Crottet, Lonneke Haer-Wigman, Peter Gowland, Stefano Fontana, Christoph Niederhauser, Hein Hustinx, Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA, Transfusion, 2013, 53, 11pt2
  8. 8
    Geoff Daniels, Variants of RhD – current testing and clinical consequences, British Journal of Haematology, 2013, 161, 4